Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin America

Background. Asymptomatic dengue virus–infected individuals are thought to play a major role in dengue virus transmission. The efficacy of the recently approved quadrivalent CYD-TDV dengue vaccine against asymptomatic dengue virus infection has not been previously assessed. Methods. We pooled data fo...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Infect Dis
Päätekijät: Olivera-Botello, Gustavo, Coudeville, Laurent, Fanouillere, Karen, Guy, Bruno, Chambonneau, Laurent, Noriega, Fernando, Jackson, Nicholas
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2016
Aiheet:
Major Articles and Brief Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5021228/
https://ncbi.nlm.nih.gov/pubmed/27418050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiw297
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia